Highlights

[CARING] YoY TTM Result on 2015-11-30 [#2]

Stock [CARING]: CARING PHARMACY GROUP BHD
Announcement Date 27-Jan-2016
Admission Sponsor -
Sponsor -
Financial Year 31-May-2016
Quarter 30-Nov-2015  [#2]
Profit Trend QoQ -     -1.31%    YoY -     24.87%
Quarter Report


View:


Show?  YoY % Horiz. %

TTM Result
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13  -  CAGR
Revenue 542,073 483,852 436,528 380,135 348,014 84,445  -  45.01%
  YoY % 12.03% 10.84% 14.83% 9.23% 312.12% - -
  Horiz. % 641.92% 572.98% 516.94% 450.16% 412.12% 100.00% -
PBT 32,693 28,397 14,659 18,705 16,007 3,569  -  55.70%
  YoY % 15.13% 93.72% -21.63% 16.86% 348.50% - -
  Horiz. % 916.03% 795.66% 410.73% 524.10% 448.50% 100.00% -
Tax -7,086 -6,838 -4,358 -5,541 -4,915 -1,342  -  39.46%
  YoY % -3.63% -56.91% 21.35% -12.74% -266.24% - -
  Horiz. % 528.02% 509.54% 324.74% 412.89% 366.24% 100.00% -
NP 25,607 21,559 10,301 13,164 11,092 2,227  -  62.93%
  YoY % 18.78% 109.29% -21.75% 18.68% 398.07% - -
  Horiz. % 1,149.84% 968.07% 462.55% 591.11% 498.07% 100.00% -
NP to SH 20,860 17,172 7,840 13,159 10,538 1,820  -  62.83%
  YoY % 21.48% 119.03% -40.42% 24.87% 479.01% - -
  Horiz. % 1,146.15% 943.52% 430.77% 723.02% 579.01% 100.00% -
Tax Rate 21.67 % 24.08 % 29.73 % 29.62 % 30.71 % 37.60 %  -  % -10.43%
  YoY % -10.01% -19.00% 0.37% -3.55% -18.32% - -
  Horiz. % 57.63% 64.04% 79.07% 78.78% 81.68% 100.00% -
Total Cost 516,466 462,293 426,227 366,971 336,922 82,218  -  44.39%
  YoY % 11.72% 8.46% 16.15% 8.92% 309.79% - -
  Horiz. % 628.17% 562.28% 518.41% 446.34% 409.79% 100.00% -
Net Worth 141,509 132,800 121,915 119,738 117,561 108,853  -  5.38%
  YoY % 6.56% 8.93% 1.82% 1.85% 8.00% - -
  Horiz. % 130.00% 122.00% 112.00% 110.00% 108.00% 100.00% -
Dividend
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13  -  CAGR
Div 21,770 13,062 6,531 4,354 3,265 3,265  -  46.11%
  YoY % 66.67% 100.00% 50.00% 33.33% 0.00% - -
  Horiz. % 666.67% 400.00% 200.00% 133.33% 100.00% 100.00% -
Div Payout % 104.37 % 76.07 % 83.31 % 33.09 % 30.99 % 179.43 %  -  % -10.26%
  YoY % 37.20% -8.69% 151.77% 6.78% -82.73% - -
  Horiz. % 58.17% 42.40% 46.43% 18.44% 17.27% 100.00% -
Equity
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13  -  CAGR
Net Worth 141,509 132,800 121,915 119,738 117,561 108,853  -  5.38%
  YoY % 6.56% 8.93% 1.82% 1.85% 8.00% - -
  Horiz. % 130.00% 122.00% 112.00% 110.00% 108.00% 100.00% -
NOSH 217,706 217,706 217,706 217,706 217,706 217,706  -  -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% - -
  Horiz. % 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% -
Ratio Analysis
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13  -  CAGR
NP Margin 4.72 % 4.46 % 2.36 % 3.46 % 3.19 % 2.64 %  -  % 12.32%
  YoY % 5.83% 88.98% -31.79% 8.46% 20.83% - -
  Horiz. % 178.79% 168.94% 89.39% 131.06% 120.83% 100.00% -
ROE 14.74 % 12.93 % 6.43 % 10.99 % 8.96 % 1.67 %  -  % 54.54%
  YoY % 14.00% 101.09% -41.49% 22.66% 436.53% - -
  Horiz. % 882.63% 774.25% 385.03% 658.08% 536.53% 100.00% -
Per Share
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13  -  CAGR
RPS 248.99 222.25 200.51 174.61 159.85 38.79  -  45.01%
  YoY % 12.03% 10.84% 14.83% 9.23% 312.09% - -
  Horiz. % 641.89% 572.96% 516.91% 450.14% 412.09% 100.00% -
EPS 9.58 7.89 3.60 6.04 4.84 0.84  -  62.67%
  YoY % 21.42% 119.17% -40.40% 24.79% 476.19% - -
  Horiz. % 1,140.48% 939.29% 428.57% 719.05% 576.19% 100.00% -
DPS 10.00 6.00 3.00 2.00 1.50 1.50  -  46.11%
  YoY % 66.67% 100.00% 50.00% 33.33% 0.00% - -
  Horiz. % 666.67% 400.00% 200.00% 133.33% 100.00% 100.00% -
NAPS 0.6500 0.6100 0.5600 0.5500 0.5400 0.5000  -  5.38%
  YoY % 6.56% 8.93% 1.82% 1.85% 8.00% - -
  Horiz. % 130.00% 122.00% 112.00% 110.00% 108.00% 100.00% -
Adjusted Per Share Value based on latest NOSH - 217,706
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13  -  CAGR
RPS 248.99 222.25 200.51 174.61 159.85 38.79  -  45.01%
  YoY % 12.03% 10.84% 14.83% 9.23% 312.09% - -
  Horiz. % 641.89% 572.96% 516.91% 450.14% 412.09% 100.00% -
EPS 9.58 7.89 3.60 6.04 4.84 0.84  -  62.67%
  YoY % 21.42% 119.17% -40.40% 24.79% 476.19% - -
  Horiz. % 1,140.48% 939.29% 428.57% 719.05% 576.19% 100.00% -
DPS 10.00 6.00 3.00 2.00 1.50 1.50  -  46.11%
  YoY % 66.67% 100.00% 50.00% 33.33% 0.00% - -
  Horiz. % 666.67% 400.00% 200.00% 133.33% 100.00% 100.00% -
NAPS 0.6500 0.6100 0.5600 0.5500 0.5400 0.5000  -  5.38%
  YoY % 6.56% 8.93% 1.82% 1.85% 8.00% - -
  Horiz. % 130.00% 122.00% 112.00% 110.00% 108.00% 100.00% -
Price Multiplier on Financial Quarter End Date
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13  -  CAGR
Date 30/11/18 30/11/17 30/11/16 30/11/15 28/11/14 29/11/13  -  -
Price 1.6500 1.9200 1.3500 2.0400 1.2600 1.8100  -  -
P/RPS 0.66 0.86 0.67 1.17 0.79 4.67  -  -32.37%
  YoY % -23.26% 28.36% -42.74% 48.10% -83.08% - -
  Horiz. % 14.13% 18.42% 14.35% 25.05% 16.92% 100.00% -
P/EPS 17.22 24.34 37.49 33.75 26.03 216.51  -  -39.71%
  YoY % -29.25% -35.08% 11.08% 29.66% -87.98% - -
  Horiz. % 7.95% 11.24% 17.32% 15.59% 12.02% 100.00% -
EY 5.81 4.11 2.67 2.96 3.84 0.46  -  66.02%
  YoY % 41.36% 53.93% -9.80% -22.92% 734.78% - -
  Horiz. % 1,263.04% 893.48% 580.43% 643.48% 834.78% 100.00% -
DY 6.06 3.13 2.22 0.98 1.19 0.83  -  48.79%
  YoY % 93.61% 40.99% 126.53% -17.65% 43.37% - -
  Horiz. % 730.12% 377.11% 267.47% 118.07% 143.37% 100.00% -
P/NAPS 2.54 3.15 2.41 3.71 2.33 3.62  -  -6.84%
  YoY % -19.37% 30.71% -35.04% 59.23% -35.64% - -
  Horiz. % 70.17% 87.02% 66.57% 102.49% 64.36% 100.00% -
Price Multiplier on Announcement Date
30/11/18 30/11/17 30/11/16 30/11/15 30/11/14 30/11/13  -  CAGR
Date 24/01/19 23/01/18 24/01/17 27/01/16 27/01/15 -  -  -
Price 1.6800 1.9000 1.3600 1.9000 1.1900 0.0000  -  -
P/RPS 0.67 0.85 0.68 1.09 0.74 0.00  -  -
  YoY % -21.18% 25.00% -37.61% 47.30% 0.00% - -
  Horiz. % 90.54% 114.86% 91.89% 147.30% 100.00% - -
P/EPS 17.53 24.09 37.77 31.43 24.58 0.00  -  -
  YoY % -27.23% -36.22% 20.17% 27.87% 0.00% - -
  Horiz. % 71.32% 98.01% 153.66% 127.87% 100.00% - -
EY 5.70 4.15 2.65 3.18 4.07 0.00  -  -
  YoY % 37.35% 56.60% -16.67% -21.87% 0.00% - -
  Horiz. % 140.05% 101.97% 65.11% 78.13% 100.00% - -
DY 5.95 3.16 2.21 1.05 1.26 0.00  -  -
  YoY % 88.29% 42.99% 110.48% -16.67% 0.00% - -
  Horiz. % 472.22% 250.79% 175.40% 83.33% 100.00% - -
P/NAPS 2.58 3.11 2.43 3.45 2.20 0.00  -  -
  YoY % -17.04% 27.98% -29.57% 56.82% 0.00% - -
  Horiz. % 117.27% 141.36% 110.45% 156.82% 100.00% - -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

497  407  524  653 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ASB 0.175+0.005 
 KANGER 0.22-0.015 
 MUIIND 0.115-0.005 
 MTOUCHE 0.06-0.005 
 PHB 0.03+0.005 
 SAPNRG 0.105-0.005 
 CAREPLS 3.18+0.03 
 HLT 1.66-0.01 
 PARLO 0.40-0.15 
 PASUKGB 0.0750.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Top Glove Investment: Is the EPF trading or investing?- A Misconception Van Gogh of Financial
2. EPF stake buoys Top Glove's rise as Covid-19 cases climb gloveharicut
3. 'THE GREATER FOOL THEORY By Dr Neoh Soon Kean (Excerpts from STOCK MARKET INVESTMENT), Calvin Tan comments THE INVESTMENT APPROACH OF CALVIN TAN
4. LCTITAN - ALL-TIME HIGH SALES VOLUME AT ELEVATED ASPS, AND... Jom & Terry
5. TOPGLOV (7113) - Top Glove spent RM 564,639,998.73 in September for Share Buyback !!! Good or Bad? Bursa Malaysia Free Trading Education
6. 热门股:速柏玛 上挑RM8.99 南洋行家论股
7. (CHOIVO CAPITAL) LCTITAN (5284) - Rising ASP's, Falling Costs, Butadiene (Glove Proxy), Hurricane, Selling For Cash (A Summary) Choivo Capital
8. TOPGLOVE: Europe is facing a double-dip recession as coronavirus second wave arrives Van Gogh of Financial
PARTNERS & BROKERS